Showing results (21-30 of 105) with videos related to
Sort By:
Pageof 11
Plos One|March 31, 2012
Age affects quantity but not quality of antibody responses after vaccination with an inactivated flavivirus vaccine against tick-borne encephalitisKarin Stiasny, Judith H Aberle, Michael Keller, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 17, 2012
Quantitative determination of IgM antibodies reduces the pitfalls in the serodiagnosis of tick-borne encephalitisK Stiasny, J H Aberle, V Chmelik, et al.The Pediatric Infectious Disease Journal|November 4, 2008
Biennial spring activity of human metapneumovirus in AustriaStephan W Aberle, Judith H Aberle, Michael J Sandhofer, et al.Clinical and Experimental Immunology|June 16, 2004
Decreased interferon-gamma response in respiratory syncytial virus compared to other respiratory viral infections in infantsJ H Aberle, S W Aberle, W Rebhandl, et al.The Pediatric Infectious Disease Journal|May 22, 2010
Human metapneumovirus subgroup changes and seasonality during epidemicsJudith H Aberle, Stephan W Aberle, Monika Redlberger-Fritz, et al.Journal of Medical Virology|June 7, 2023
Respiratory syncytial virus surge in 2022 caused by lineages already present before the COVID-19 pandemicMonika Redlberger-Fritz, David N Springer, Stephan W Aberle, et al.The Journal of Infectious Diseases|January 29, 2003
Adenovirus DNA in serum of children hospitalized due to an acute respiratory adenovirus infectionStephan W Aberle, Judith H Aberle, Christoph Steininger, et al.The Pediatric Infectious Disease Journal|July 7, 2005
Single versus dual respiratory virus infections in hospitalized infants: impact on clinical course of disease and interferon-gamma responseJudith H Aberle, Stephan W Aberle, Elisabeth Pracher, et al.Scientific Reports|July 15, 2026
Variant-specific and cross-reactive antibody responses following COVID-19 booster vaccinations and SARS-CoV-2 breakthrough infectionsIris Medits-Weiss, Dominik Moll, David N Springer, et al.Nature Medicine|December 10, 1998
In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus modelC W Mandl, J H Aberle, S W Aberle, et al.Pageof 11